Literature DB >> 27981604

Malondialdehyde epitopes are sterile mediators of hepatic inflammation in hypercholesterolemic mice.

Clara Jana-Lui Busch1,2, Tim Hendrikx1,2,3, David Weismann1,2, Sven Jäckel4,5, Sofie M A Walenbergh3, André F Rendeiro2, Juliane Weißer2, Florian Puhm1,2, Anastasiya Hladik2,6, Laura Göderle1,2, Nikolina Papac-Milicevic1,2, Gerald Haas1,2, Vincent Millischer1,2, Saravanan Subramaniam4, Sylvia Knapp2,6, Keiryn L Bennett2, Christoph Bock1,2,7, Christoph Reinhardt4,5, Ronit Shiri-Sverdlov3, Christoph J Binder1,2.   

Abstract

Diet-related health issues such as nonalcoholic fatty liver disease and cardiovascular disorders are known to have a major inflammatory component. However, the exact pathways linking diet-induced changes (e.g., hyperlipidemia) and the ensuing inflammation have remained elusive so far. We identified biological processes related to innate immunity and oxidative stress as prime response pathways in livers of low-density lipoprotein receptor-deficient mice on a Western-type diet using RNA sequencing and in silico functional analyses of transcriptome data. The observed changes were independent of the presence of microbiota and thus indicative of a role for sterile triggers. We further show that malondialdehyde (MDA) epitopes, products of lipid peroxidation and markers for enhanced oxidative stress, are detectable in hepatic inflammation predominantly on dying cells and stimulate cytokine secretion as well as leukocyte recruitment in vitro and in vivo. MDA-induced cytokine secretion in vitro was dependent on the presence of the scavenger receptors CD36 and MSR1. Moreover, in vivo neutralization of endogenously generated MDA epitopes by intravenous injection of a specific MDA antibody results in decreased hepatic inflammation in low-density lipoprotein receptor-deficient mice on a Western-type diet.
CONCLUSION: Accumulation of MDA epitopes plays a major role during diet-induced hepatic inflammation and can be ameliorated by administration of an anti-MDA antibody. (Hepatology 2017;65:1181-1195).
© 2016 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27981604      PMCID: PMC5892702          DOI: 10.1002/hep.28970

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  45 in total

Review 1.  The intestinal microbiota in chronic liver disease.

Authors:  Jorge Henao-Mejia; Eran Elinav; Christoph A Thaiss; Richard A Flavell
Journal:  Adv Immunol       Date:  2013       Impact factor: 3.543

2.  Atheroprotective immunization with malondialdehyde-modified LDL is hapten specific and dependent on advanced MDA adducts: implications for development of an atheroprotective vaccine.

Authors:  Ayelet Gonen; Lotte F Hansen; William W Turner; Erica N Montano; Xuchu Que; Apaїs Rafia; Meng-Yun Chou; Philipp Wiesner; Dimitrios Tsiantoulas; Maripat Corr; Michael S VanNieuwenhze; Sotirios Tsimikas; Christoph J Binder; Joseph L Witztum; Karsten Hartvigsen
Journal:  J Lipid Res       Date:  2014-08-20       Impact factor: 5.922

3.  Malondialdehyde-acetaldehyde adduct is the dominant epitope after MDA modification of proteins in atherosclerosis.

Authors:  Michael J Duryee; Lynell W Klassen; Courtney S Schaffert; Dean J Tuma; Carlos D Hunter; Robert P Garvin; Daniel R Anderson; Geoffrey M Thiele
Journal:  Free Radic Biol Med       Date:  2010-08-06       Impact factor: 7.376

Review 4.  Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.

Authors:  Kenneth Cusi
Journal:  Gastroenterology       Date:  2012-02-08       Impact factor: 22.682

5.  Experimental liver cirrhosis induced by alcohol and iron.

Authors:  H Tsukamoto; W Horne; S Kamimura; O Niemelä; S Parkkila; S Ylä-Herttuala; G M Brittenham
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

6.  Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice.

Authors:  Evis Harja; De-xiu Bu; Barry I Hudson; Jong Sun Chang; Xiaoping Shen; Kellie Hallam; Anastasia Z Kalea; Yan Lu; Rosa H Rosario; Sai Oruganti; Zana Nikolla; Dmitri Belov; Evanthia Lalla; Ravichandran Ramasamy; Shi Fang Yan; Ann Marie Schmidt
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

7.  Proinflammatory effects of advanced lipoxidation end products in monocytes.

Authors:  Narkunarajaa Shanmugam; James L Figarola; Yan Li; Piotr M Swiderski; Samual Rahbar; Rama Natarajan
Journal:  Diabetes       Date:  2007-11-14       Impact factor: 9.461

8.  Peptide mimotopes of malondialdehyde epitopes for clinical applications in cardiovascular disease.

Authors:  Shahzada Amir; Karsten Hartvigsen; Ayelet Gonen; Gregor Leibundgut; Xuchu Que; Erika Jensen-Jarolim; Oswald Wagner; Sotirios Tsimikas; Joseph L Witztum; Christoph J Binder
Journal:  J Lipid Res       Date:  2012-04-16       Impact factor: 5.922

9.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Authors:  Jorge Henao-Mejia; Eran Elinav; Chengcheng Jin; Liming Hao; Wajahat Z Mehal; Till Strowig; Christoph A Thaiss; Andrew L Kau; Stephanie C Eisenbarth; Michael J Jurczak; Joao-Paulo Camporez; Gerald I Shulman; Jeffrey I Gordon; Hal M Hoffman; Richard A Flavell
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962

10.  Effect of diet on expression of genes involved in lipid metabolism, oxidative stress, and inflammation in mouse liver-insights into mechanisms of hepatic steatosis.

Authors:  Helen J Renaud; Julia Y Cui; Hong Lu; Curtis D Klaassen
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

View more
  15 in total

1.  AGR2-induced cholesterol synthesis drives lovastatin resistance that is overcome by combination therapy with allicin.

Authors:  Nan Sheng; Yun-Qiu Wang; Cun-Fu Wang; Meng-Qi Jia; Huan-Min Niu; Qi-Qi Lu; Ya-Nan Wang; Dan Feng; Xiao-Xue Zheng; Hui-Qing Yuan
Journal:  Acta Pharmacol Sin       Date:  2022-04-22       Impact factor: 6.150

2.  PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes With a Human Antibody Detects Clinically Relevant Atherothrombosis.

Authors:  Max L Senders; Xuchu Que; Young Seok Cho; Calvin Yeang; Hannah Groenen; Francois Fay; Claudia Calcagno; Anu E Meerwaldt; Simone Green; Phuong Miu; Mark E Lobatto; Thomas Reiner; Zahi A Fayad; Joseph L Witztum; Willem J M Mulder; Carlos Pérez-Medina; Sotirios Tsimikas
Journal:  J Am Coll Cardiol       Date:  2018-01-23       Impact factor: 24.094

3.  Direct antioxidant properties of methotrexate: Inhibition of malondialdehyde-acetaldehyde-protein adduct formation and superoxide scavenging.

Authors:  Matthew C Zimmerman; Dahn L Clemens; Michael J Duryee; Cleofes Sarmiento; Andrew Chiou; Carlos D Hunter; Jun Tian; Lynell W Klassen; James R O'Dell; Geoffrey M Thiele; Ted R Mikuls; Daniel R Anderson
Journal:  Redox Biol       Date:  2017-08-02       Impact factor: 11.799

4.  A genome-wide association study identifies key modulators of complement factor H binding to malondialdehyde-epitopes.

Authors:  Lejla Alic; Nikolina Papac-Milicevic; Darina Czamara; Ramona B Rudnick; Maria Ozsvar-Kozma; Andrea Hartmann; Michael Gurbisz; Gregor Hoermann; Stefanie Haslinger-Hutter; Peter F Zipfel; Christine Skerka; Elisabeth B Binder; Christoph J Binder
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-22       Impact factor: 11.205

5.  Monophosphoryl lipid A alleviated radiation-induced testicular injury through TLR4-dependent exosomes.

Authors:  Zhe Liu; Kun Cao; Zebin Liao; Yuanyuan Chen; Xiao Lei; Qun Wei; Cong Liu; Xuejun Sun; Yanyong Yang; Jianming Cai; Fu Gao
Journal:  J Cell Mol Med       Date:  2020-03-05       Impact factor: 5.310

6.  The Microbiota Promotes Arterial Thrombosis in Low-Density Lipoprotein Receptor-Deficient Mice.

Authors:  Klytaimnistra Kiouptsi; Sven Jäckel; Giulia Pontarollo; Emiel P C van der Vorst; Yvonne Döring; Christoph Reinhardt; Alexandra Grill; Marijke J E Kuijpers; Eivor Wilms; Christian Weber; Felix Sommer; Magdolna Nagy; Carlos Neideck; Yvonne Jansen; Stefanie Ascher; Henning Formes; Cornelia Karwot; Franziska Bayer; Bettina Kollar; Saravanan Subramaniam; Michael Molitor; Philip Wenzel; Philip Rosenstiel; Hristo Todorov; Susanne Gerber; Ulrich Walter; Kerstin Jurk; Johan W M Heemskerk
Journal:  mBio       Date:  2019-10-22       Impact factor: 7.867

Review 7.  Nonalcoholic Fatty Liver Disease.

Authors:  Lingling Ding; Yvonne Oligschlaeger; Ronit Shiri-Sverdlov; Tom Houben
Journal:  Handb Exp Pharmacol       Date:  2022

8.  Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis.

Authors:  Uta Hardt; Anders Larsson; Iva Gunnarsson; Robert M Clancy; Michelle Petri; Jill P Buyon; Gregg J Silverman; Elisabet Svenungsson; Caroline Grönwall
Journal:  Arthritis Res Ther       Date:  2018-02-26       Impact factor: 5.156

Review 9.  Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism.

Authors:  Sander Lefere; Frank Tacke
Journal:  JHEP Rep       Date:  2019-02-23

Review 10.  Current Understanding of Natural Antibodies and Exploring the Possibilities of Modulation Using Veterinary Models. A Review.

Authors:  G IJsbrand Reyneveld; Huub F J Savelkoul; Henk K Parmentier
Journal:  Front Immunol       Date:  2020-09-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.